Page last updated: 2024-09-04

butyryl-n-trihexylcitrate and cardiovascular agents

butyryl-n-trihexylcitrate has been researched along with cardiovascular agents in 3 studies

Compound Research Comparison

Studies (butyryl-n-trihexylcitrate)	Trials (butyryl-n-trihexylcitrate)	Recent Studies (post-2010) (butyryl-n-trihexylcitrate)	Studies (cardiovascular agents)	Trials (cardiovascular agents)	Recent Studies (post-2010) (cardiovascular agents)
12	2	5	17,645	1,480	6,891

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bayer, G; Byrne, RA; Hartwig, S; Joner, M; Joost, A; Radke, PW; Steigerwald, K; Wittchow, E	1
Lammer, J; Scheinert, D; Schulte, KL; Tepe, G; Zeller, T	1
Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F	1

Trials

1 trial(s) available for butyryl-n-trihexylcitrate and cardiovascular agents

Article	Year
Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2015, Volume: 22, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Ankle Brachial Index; Austria; Butyrates; Cardiovascular Agents; Coated Materials, Biocompatible; Excipients; Female; Femoral Artery; Follow-Up Studies; Germany; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Radiography; Treatment Outcome	2015

Article

Year

Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2015, Volume: 22, Issue:1

Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Ankle Brachial Index; Austria; Butyrates; Cardiovascular Agents; Coated Materials, Biocompatible; Excipients; Female; Femoral Artery; Follow-Up Studies; Germany; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Radiography; Treatment Outcome

2015

Other Studies

2 other study(ies) available for butyryl-n-trihexylcitrate and cardiovascular agents

Article	Year
Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Oct-30, Volume: 7, Issue:6 Topics: Angioplasty, Balloon, Coronary; Animals; Butyrates; Cardiovascular Agents; Citrates; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Equipment Design; Excipients; Female; Iohexol; Lecithins; Male; Models, Animal; Paclitaxel; Sus scrofa; Time Factors; Wound Healing	2011
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons. Coronary artery disease, 2018, Volume: 29, Issue:8 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2018

Article

Year

Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Oct-30, Volume: 7, Issue:6

Topics: Angioplasty, Balloon, Coronary; Animals; Butyrates; Cardiovascular Agents; Citrates; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Equipment Design; Excipients; Female; Iohexol; Lecithins; Male; Models, Animal; Paclitaxel; Sus scrofa; Time Factors; Wound Healing

2011

Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.

Coronary artery disease, 2018, Volume: 29, Issue:8

Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2018